Acquire the license to the best health content in the world
Contact Us

Midlife Diabetes May Contribute to Later Cognitive Decline

Midlife hypertension also may affect cognition later in life

Midlife Diabetes May Contribute to Later Cognitive Decline

THURSDAY, March 20, 2014 (HealthDay News) -- Midlife onset of diabetes and hypertension each may contribute to cognitive impairment later in life, according to research published online March 19 in Neurology.

Rosebud O. Roberts, M.B., Ch.B., of the Mayo Clinic in Rochester, Minn., and colleagues reviewed medical records and conducted neuropsychological testing and magnetic resonance imaging for 1,437 participants (median age, 80 years) in a population-based cohort without dementia. The researchers investigated the associations of diabetes and hypertension with cognition and imaging biomarkers of brain pathology.

The researchers found that participants with midlife diabetes were more likely to have subcortical infarctions (odds ratio [OR], 1.85; 95 percent confidence interval [CI], 1.09 to 3.15; P = 0.02), reduced hippocampal volume (−4 percent; 95 percent CI, −7 to −1.0 percent; P = 0.01), reduced whole brain volume (−2.9 percent; 95 percent CI, −4.1 to −1.6 percent), and prevalent mild cognitive impairment (OR, 2.08; P = 0.01). Midlife hypertension was linked with infarctions and white matter hyperintensity volume and was marginally linked with decreased performance in executive function. Participants with late-life onset of diabetes and hypertension appeared to have few effects.

"Midlife onset of diabetes may affect late-life cognition through loss of brain volume. Midlife hypertension may affect executive function through ischemic pathology," the authors write. "Late-life onset of these conditions had fewer effects on brain pathology and cognition."

Several study authors disclosed financial ties to pharmaceutical and biomedical companies.

Abstract
Full Text (subscription or payment may be required)

Physician's Briefing